Company / Operating Cash Flow per Share
STAAR Surgical Company Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.69
FY2025
5-year range
-$0.69 / $0.75
FY2021-FY2025
Trend
-315.7%
vs FY2024
Sector context
#147 of 161
Health Care
What the data says
Operating Cash Flow per Share changed -316% YoY in FY2025, a notable deviation from the 9-year average annual change of +190%.
Based on SEC 10-K filings.
-0.69 in FY2025.
Declined from $0.30 to $-0.69 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 161This company -$0.69 Sector average $6.67
▼
-110.4% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 315.7% year-over-year.
- Ranks #147 out of 161 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2016.
- Lowest operating cash flow per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Negative profit margin: -6.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.69 | -315.7% |
| FY2024 | $0.32 | +6.4% |
| FY2023 | $0.30 | -59.6% |
| FY2022 | $0.75 | +34.9% |
| FY2021 | $0.55 | +94.8% |
| FY2020 | $0.28 | -51.2% |
| FY2019 | $0.58 | +2202.5% |
| FY2018 | $0.03 | +100.0% |
| FY2017 | -$53.08 | -301.8% |
| FY2016 | $26.30 | +146.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026